Biotechnology News

March 22, 2012

AUSTIN, Texas--(BUSINESS WIRE)--RNA Cleared by FDA Pre-analytical RNA Stabilization Device, RNA Retain, clinically validated and cGMP manufactured. RNA Later

March 22, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Itamar-Medical will unveil its cardiovascular healthcare assessment platform, EndoPAT-MF, at the upcoming American College of Cardiology Conference in Chicago.

March 22, 2012

EXTON, Pa.--(BUSINESS WIRE)--Twelve months post-launch of KRYSTEXXA, surveyed rheumatologists appear to have high awareness of KRYSTEXXA and reserve it for chronic refractory gout patients

March 22, 2012

ST. LOUIS--(BUSINESS WIRE)--Mallinckrodt, the pharmaceuticals business of Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of its morphine sulfate oral solution for the relief of moderate-to-...

March 22, 2012

WASHINGTON--(BUSINESS WIRE)--BIO announces nominations are open for 4th annual Biotech Humanitarian Award. The Award will be given at the 2012 Biotechnology International Convention in Boston June 19-21

March 22, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Euthymics announced that it has initiated a Phase 1 clinical trial of EB-1020, a next-generation drug in development for treating adult ADHD, with low risk of drug abuse liability.

March 22, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the fourth quarter and year ended December 31, 2011.

March 22, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical robots and complementary products, today announced that the company will host conference calls on Wednesday, March 28, 2012 to discuss fourth...

March 22, 2012

PARIS--(BUSINESS WIRE)--Exonhit announces 2011 financial results (decrease in net loss, repayment of debt, approximately 24 months of cash), highlights key points for 2011 and perspectives 2012.

March 21, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex:BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer, Michael D. West, Ph.D., will present...

March 21, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--ConforMIS, Inc. filed documents to initiate an interference proceeding in the United States Patent and Trademark Office involving a patent application held by Imperial Innovations Group.

March 21, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.ob - News), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce its acquisition of The Kaneabis Brand through its parent...

March 21, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Freshmedx announced its study on the use of computed biconductance technology in detecting lung cancer will be published in the April 2012 Journal of Thoracic Oncology.

March 21, 2012

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Shareholders in Moberg Derma AB (publ) (reg. no. 556697-7426) (the “Company”) are hereby convened to the Annual General Meeting on Monday, April 23, 2012 at 5:30 p.m. in the Company´s premises...

March 21, 2012

AMSTERDAM--(BUSINESS WIRE)--BIO-Europe Spring® 2013 to be held in Barcelona

March 21, 2012

LONDON & AMSTERDAM--(BUSINESS WIRE)--Novel EUR 150 million collaborative investment announced at BIO-Europe Spring® 2012 in Amsterdam

March 21, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue,...

March 21, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it is transferring the listing of its American Depositary Shares (“ADSs”), each representing one ordinary share of Teva common stock, to the New...

March 21, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced additional analyses from the ARISTOTLE and AVERROES clinical trials will be presented at the American College of...

March 21, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that Nancy A. Simonian, M.D. has been appointed to the company’s Board of Directors. Dr. Simonian is a biotechnology veteran with more than 16 years of global...

March 21, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) and The Baxter International Foundation, the philanthropic arm of Baxter, today announced combined charitable giving of more than $80 million in 2011. The company was also...

March 21, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on clinical data and the opinions of interviewed thought leaders, Pluristem...

March 21, 2012

COPENHAGEN, Denmark--(BUSINESS WIRE)--Unilabs today announced the one-year status on testing in Europe and several other markets outside Europe with the CE marked ELISA test STRATIFY JCV®. STRATIFY JCV is an important tool used to help enable...

March 21, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus announced submission of IDE supplement to FDA proposed Phase III trial of the INTERCEPT Blood System for red cells in patients receiving chronic red cell transfusion support.

March 21, 2012

TOKYO--(BUSINESS WIRE)--Bridge Report on CellSeed Issued: FY12/11 Earnings in Line with Revised Estimates, the Company Calls for Operating Losses on Back of Anticipatory Investments and Despite Sales Growth in FY12/12

March 21, 2012

MANCHESTER, UK & ANIF, Austria--(BUSINESS WIRE)--Shimadzu Corporation MALDI Business Unit and Sony DADC develop application-specific, individually-barcoded, disposable MALDI targets for regulated and non-regulated environments.

March 21, 2012

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the appointment of Susan Vissers Lisa, CFA, as Senior Director of Investor Relations and Corporate...

March 21, 2012

SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, today announced that Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and CEO, is scheduled to...

March 21, 2012

CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare, the healthcare business of GE (NYSE: GE) announced today the official opening of its expanded Fast Trak Training Center in Shanghai, China. The opening ceremony was hosted by Kieran...

March 21, 2012

CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B...

March 21, 2012

DUBLIN, Calif.--(BUSINESS WIRE)--Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the Agenda for its Annual Analyst and Investor...

March 21, 2012

NEWARK, Del.--(BUSINESS WIRE)--Fraunhofer USA Center for Molecular Biotechnology (CMB), a not-for-profit, Delaware-based organization focused on developing a proprietary plant-based protein production platform and its applications in vaccine and...

March 21, 2012

LONDON--(BUSINESS WIRE)--Index Ventures today announced the launch of its first fund solely dedicated to making investments in the life sciences sector. This €150m fund includes investments from several of Index’s largest existing limited...

March 21, 2012

KOLKATA, India--(BUSINESS WIRE)--CHEMGEN Pharma International, a Dr. Kali Pradip Chaudhuri Company, Appoints Dr. Debasis Das as General Manager of Business Development

March 20, 2012

WHITEHOUSE STATION, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and ARIAD Pharmaceuticals, Inc., (NASDAQ:ARIA), announced today that the U.S. Food and Drug Administration’s (...

March 20, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel reports fourth quarter and year-end earnings

March 20, 2012

MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt...

March 20, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, is hosting an educational webinar entitled “Producing Gram Scale Quantities of Antibodies and Proteins Using MaxCyte®...

March 20, 2012

WASHINGTON--(BUSINESS WIRE)--Press Kit Materials are Available at: http://www.tradeshownews.com/...

March 20, 2012

PARIS--(BUSINESS WIRE)--« Oncology: key issues for the future » - Success of the first BioAlliance Pharma’s symposium

March 20, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX), discussed encapsulation, freezing, storage, survivability and localization of human stem cells in Cell-in-a-Box® technology.

March 20, 2012

WASHINGTON--(BUSINESS WIRE)--Voting for the 2012 BIO International Convention Buzz of BIO will open Monday, April 2, 2012. BIO is asking voters to look for innovative biotech companies that are R&D intensive.

March 20, 2012

FORT LEE, N.J.--(BUSINESS WIRE)--Computerworld honors SAFE-BioPharma standard for role accelerating initiation of a cancer clinical trial while lowering costs and reducing paper-reliance.

March 20, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Astepro (STO:MEDAA) has received registration approval in Europe via the decentralized procedure. Astepro is a new nasal spray for the treatment of allergic rhinitis. National registration...

March 20, 2012

MOSCOW--(BUSINESS WIRE)--Maxwell Biotech Venture Fund (MBVF), founded with the participation of the Russian Government’s Russian Venture Company, announced today its first investment involving the High-Tech Gründerfonds.

March 20, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced that it has begun a collaboration with The University of Texas MD Anderson Cancer Center to evaluate the use of the Company’s very high sensitivity ICE COLD-PCR...

March 20, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--In honor of the first ever HAE Day upcoming on May 16, 2012, Dyax Corp. (NASDAQ: DYAX), the manufacturer of KALBITOR® (ecallantide) for the treatment of acute attacks of HAE in patients 16 years of age and...

March 20, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis continues collaboration with Dr. Samir Khleif

March 20, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has appointed David M. Sabatini, MD, PhD, to its Scientific Advisory Board. The Board was formed in 2010 to...